Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.

Lane H-Y, Huang C-L, Wu P-L, Liu Y-C, Chang Y-C, Lin P-Y, et al. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biol Psychiatry. 2006;60(6):645-9. DOI: 10.1016/j.biopsych.2006.04.005. PubMed PMID: 16780811.

Effects of typical and atypical antipsychotics on human glycine transporters.

Williams JB, Mallorga PJ, Conn PJ, Pettibone DJ, Sur C. Effects of typical and atypical antipsychotics on human glycine transporters. Schizophr Res. 2004;71(1):103-12. DOI: 10.1016/j.schres.2004.01.013. PubMed PMID: 15374578.

Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes.

Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M. Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Br J Pharmacol. 2012;165(5):1543-55. DOI: 10.1111/j.1476-5381.2011.01638.x. PubMed PMID: 21880034.

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158(3):360-9. DOI: 10.1176/appi.ajp.158.3.360. PubMed PMID: 11229973.

Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang R-H, Nasrallah HA. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry. 2002;63(10):920-30. PubMed PMID: 12416602.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer J-P, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, et al. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. AJP. 2003;160(2):290-6. DOI: 10.1176/appi.ajp.160.2.290. PubMed PMID: 12562575.

Community Evidence of Clozapine's Effectiveness.

Marder SR. Community Evidence of Clozapine's Effectiveness. Am J Psychiatry. 2016;173(2):103-4. DOI: 10.1176/appi.ajp.2015.15111466. PubMed PMID: 26844790.

Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.

Stone-Brown K, Naji M, Francioni A, Myers K, Samarendra H, Mushtaq-Chaudhry H, et al. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital. CNS Spectr. 2016;21(1):60-9. DOI: 10.1017/S1092852915000784. PubMed PMID: 26726766.

Revisiting the discussion: termination of clozapine treatment due to renal failure.

Woesner ME, Kanofsky JD. Revisiting the discussion: termination of clozapine treatment due to renal failure. J Clin Psychiatry. 2015;76(12):1694. DOI: 10.4088/JCP.15lr10019. PubMed PMID: 26717530.

Dr. Nielsen and colleagues reply.

Nielsen J, Manu P, Kane JM, Correll CU. Dr. Nielsen and colleagues reply. J Clin Psychiatry. 2015;76(12):1694-5. DOI: 10.4088/JCP.15lr10019a. PubMed PMID: 26717531.